Self-assembled biotransesterified cyclodextrins as potential Artemisinin nanocarriers. II: In vitro behavior toward the immune system and in vivo biodistribution assessment of unloaded nanoparticles

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 88, Issue 3, 2014, Pages 683-694

  Yaméogo, Josias B G ^a,c   Gèze, Annabelle ^a   Choisnard, Luc ^a   Putaux, Jean Luc ^b   Mazet, Roseline ^a   Passirani, Catherine ^d   Keramidas, Michelle ^a,e   Coll, Jean Luc ^a,e   Lautram, Nolwenn ^d   Bejaud, Jérôme ^d   Semdé, Rasmané ^c   Wouessidjewe, Denis ^a  

^a UNIV GRENOBLE ALPES   (France)

^b CENTRE DE RECHERCHES SUR LES MACROMOLÉCULES VÉGÉTALES CERMAV CNRS   (France)

^c UNIVERSITÉ DE OUAGADOUGOU   (Burkina Faso)

^d UNIVERSITÉ D'ANGERS   (France)

^e INSERM   (France)

Author keywords

Artemisinin; Biodistribution; Bioesterified cyclodextrins; Co nanoprecipitation; Hemolytic properties; PEGylated amphiphile; Stealth properties; Surface decorated nanoparticles

Indexed keywords

ARTEMISININ; CYCLODEXTRIN; MACROGOL 2000; NANOSPHERE; POLYSORBATE 80; ANTIINFECTIVE AGENT; ARTEMISININ DERIVATIVE; DRUG CARRIER; NANOPARTICLE;

ANIMAL EXPERIMENT; ARTICLE; BLADDER; BRAIN; CIRCULATION; CYTOTOXICITY; DRUG DISTRIBUTION; FEMALE; FLUORESCENCE IMAGING; HEMOLYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNE SYSTEM; IN VITRO STUDY; IN VIVO STUDY; INTESTINE; KIDNEY; LIVER; MACROPHAGE; MOUSE; MUSCLE; NONHUMAN; OVARY; PANCREAS; PHAGOCYTOSIS; SKIN; SPLEEN; STOMACH; TRANSMISSION ELECTRON MICROSCOPY; UTERUS; ANIMAL; BLOOD; CELL LINE; CHEMISTRY; COMPLEMENT ACTIVATION; DRUG EFFECTS; DRUG STABILITY; ERYTHROCYTE; HUMAN; IMMUNOLOGY; NUDE MOUSE; PARTICLE SIZE; SHEEP; SURFACE PROPERTY; TISSUE DISTRIBUTION;

ANIMALS; ANTI-INFECTIVE AGENTS; ARTEMISININS; CELL LINE; COMPLEMENT ACTIVATION; CYCLODEXTRINS; DRUG CARRIERS; DRUG STABILITY; ERYTHROCYTES; HEMOLYSIS; HUMANS; IMMUNE SYSTEM; MACROPHAGES; MICE, NUDE; NANOPARTICLES; PARTICLE SIZE; PHAGOCYTOSIS; SHEEP; SURFACE PROPERTIES; TISSUE DISTRIBUTION;

EID: 84912082503     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2014.08.012     Document Type: Article

References (40)

1. World Health Organization (WHO), The Use of Antimalarial Drugs: Report of a WHO Informal Consultation 13-17 November, 2001 (WHO/CS/RBM/2001.33).
2. M.E. Van Agtmael, T.A. Eggelte, and C.J. van Boxtel Artemisinin drugs in the treatment of malaria: from medicinal herb to registered medication TiPS 20 1999 199 205
3. J.W. Wong, and K.H. Yuen Inclusion complexation of artemisinin with α-, β- and γ-cyclodextrins Drug Dev. Ind. Pharm. 29 2003 1035 1044
4. J.W. Wong, and K.H. Yuen Improved oral bioavailability of artemisinin through inclusion complexation β- and γ-cyclodextrins Int. J. Pharm. 227 2001 177 185
5. N.G. Sahoo, A. Abbas, Z. Judeh, C.M. Li, and K-H. Yuen Solubility enhancement of poorly water-soluble antimalarial drug: experimental design and use of a modified multifluid nozzle pilot spray drier J. Pharm. Sci. 98 1 2009 281 296
6. B. Isacchi, S. Arrigucci, G. la Marca, M.C. Bergonzi, M.G. Vannucchi, A. Novelli, and A.R. Bilia Conventional and long-circulating liposomes of artemisinin: preparation, characterization, and pharmacokinetic profile in mice. J. Liposome Res. 21 3 2011 237 244
7. B. Isacchi, M.C. Bergonzi, M. Grazioso, C. Righeschi, A. Pietretti, C. Severini, and A.R. Bilia Artemisinin and artemisinin plus curcumin liposomal formulations: enhanced antimalarial efficacy against Plasmodium berghei-infected mice Eur. J. Pharm. Biopharm. 80 3 2012 528 534
8. J.B.G. Yaméogo, A. Gèze, L. Choisnard, J-L. Putaux, A. Gansané, S.B. Sirima, R. Semdé, and D. Wouessidjewe Self-assembled biotransesterified cyclodextrins as Artemisinin nanocarriers. I: Formulation, lyoavailability and in vitro antimalarial activity assessment Eur. J. Pharm. Biopharm. 80 3 2012 508 517
9. L. Choisnard, A. Gèze, C. Vanharverbeke, J.B.G. Yaméogo, J.-L. Putaux, B. Brasme, L. Julien, S. Boulanger, C. Elfakir, and D. Wouessidjewe Physicochemical characterization of α-, β- and γ-cyclodextrins bioesterified with decanoate chains used as building blocks of colloidal nanoparticles Biomacromolecules 12 8 2011 3031 3038
10. L. Choisnard, A. Gèze, J-L. Putaux, Y.S. Wong, and D. Wouessidjewe Novel nanoparticles of β-cyclodextrin esters obtained by self-assembling of bio-transesterified β-cyclodextrins Biomacromolecules 7 2006 515 520
11. L. Choisnard, A. Gèze, B.G.J. Yaméogo, J-L. Putaux, and D. Wouessidjewe Miscellaneous nanoaggregates made of CD esters synthesised by an enzymatic pathway Int. J. Pharm. 344 2007 26 32
12. A. Gèze, L. Choisnard, J-L. Putaux, and D. Wouessidjewe Colloidal systems made of biotransesterified cyclodextrins grafted with C10 alkyl chains Mater. Sci. Eng. C 29 2009 458 462
13. J.B.G. Yaméogo, A. Gèze, L. Choisnard, J-L. Putaux, S. Semde, and D. Wouessidjewe Progress in developing amphiphilic cyclodextrin-based nanodevices for drug delivery Curr. Top. Med. Chem. 14 2014 526 541
14. P. Couvreur, and C. Vauthier Nanotechnology: intelligent design to treat complex disease Pharm. Res. 27 7 2006 1417 1450
15. A. Gèze, L. Tieu Chau, L. Choisnard, J.P. Mathieu, D. Marti-Battle, L. Riou, J-L. Putaux, and D. Wouessidjewe Biodistribution of intravenously administrated amphiphilic β-cyclodextrin nanospheres Int. J. Pharm. 344 1-2 2007 135 142
16. S.M. Moghimi, A.C. Hunter, and J.C. Murray Long-circulating and target-specific nanoparticles: theory and practice Pharmacol. Rev. 53 2001 283 318
17. S.M. Moghimi, and J. Szebeni Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties Prog. Lipid Res. 42 2003 463 478
18. A. Vonarbourg, C. Passirani, P. Saulnier, and J-P. Benoit Parameters influencing the stealthiness of colloidal drug delivery systems Biomaterials 27 24 2006 4356 4373
19. C. Passirani, G. Barrat, J-P. Devissaguet, and D. Labarre Interactions of nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate) with the complement system Life Sci. 62 8 1998 775 785
20. C. Vauthier, C. Schmidt, and P. Couvreur Measurement of the density of polymeric nanoparticulate drug carriers by isopycnic centrifugation J. Nanopart. Res. 1 1999 411 418
21. B.A. Avery, K.K. Venkatesh, and M.A. Avery Rapid determination of artemisinin and related analogues using high-performance liquid chromatography and an evaporative light scattering detector J. Chromatogr. B 730 1999 71 80
22. M. Morille, T. Montier, P. Legras, N. Carmoy, P. Brodin, B. Pitard, J-P. Benoit, and C. Passirani Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting Biomaterials 31 2 2010 321 329
23. E. Garcion, A. Lamprecht, B. Heurtault, A. Paillard, A. Aubert-Pouessel, B. Denizot, P. Menei, and J.P. Benoit A new generation of anticancer, drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in rats Mol. Cancer Ther. 5 7 2005 1710 1722
24. A. Béduneau, P. Saulnier, N. Anton, F. Hindré, C. Passirani, H. Rajerison, N. Noiret, and J-P. Benoit Pegylated nanocapsules produced by an organic solvent-free method: evaluation of their stealth properties Pharm. Res. 23 9 2006 2190 2199
25. A. Vonarbourg, C. Passirani, P. Saulnier, P. Simard, J. Leroux, and J-P. Benoit Evaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptake J. Biomed. Mater. Res. A 78 3 2006 620 628
26. A. Paillard, C. Passirani, P. Saulnier, M. Kroubi, E. Garcion, J-P. Benoit, and D. Betbeder Positively-charged, porous, polysaccharide nanoparticles loaded with anionic molecules behave as stealth cationic nanocarriers Pharm. Res. 27 1 2010 126 133
27. L. Sancey, S. Dufort, V. Joserand, M. Keramidas, C. Righini, C. Rome, A.C. Faure, S. Foillard, S. Roux, D. Boturyn, O. Tillement, A. Koenig, J. Boutet, P. Rizo, P. Dumy, and J.-L. Coll Drug development in oncology assisted by noninvasive optical imaging Int. J. Pharm. 379 2009 309 316
28. I. Texier, M. Goutayer, A. Da Silva, L. Guyon, N. Djaker, V. Josserand, E. Neumann, J. Bibette, and F. Vinet Cyanine-loaded lipid nanoparticles for improved in vivo fluorescence imaging J. Biomed. Opt. 14 5 2009 1 11 05400
29. S. Dufort, L. Sancey, C. Wenk, V. Josserand, and J-L. Coll Optical small animal imaging in the drug discovery process Biochim. Biophys. Acta 1798 12 2010 2266 2273
30. M. Goutayer, S. Dufort, V. Josserand, A. Royère, E. Heinrich, F. Vinet, J. Bibette, J-L. Coll, and I. Texier Tumor targeting of functionalized lipid nanoparticles: assessment by in vivo fluorescence imaging Eur. J. Pharm. Biopharm. 75 2 2010 137 147
31. A.C. Faure, S. Dufort, V. Josserand, P. Perriat, J-L. Coll, S. Roux, and O. Tillement Control of the in vivo biodistribution of hybrid nanoparticles with different poly(ethylene glycol) coatings Small 5 2009 2565 2575
32. A. Vonarbourg, P. Saulnier, C. Passirani, and J-P. Benoit Electrokinetic properties of noncharged lipid nanocapsules: influence of the dipolar distribution at the interface Electrophoresis 26 2005 2066 2075
33. M. Morille, C. Passirani, S. Dufort, G. Bastia, B. Pitard, J.L. Coll, and J-P. Benoit Tumor transfection after systemic injection of DNA lipid nanocapsules Biomaterials 31 2 2011 2327 2333
34. E. Bilensoy, O. Gurkaynak, A.L. Dogan, and A.A. Hincal Safety and efficacy of amphiphilic beta-cyclodextrin nanoparticles for paclitaxel delivery Int. J. Pharm. 347 2008 163 170
35. F. Quaglia, L. Ostacolo, A. Mazzaglia, V. Villari, D. Zaccaria, and M.T. Sciortino The intracellular effects of non-ionic amphiphilic cyclodextrin nanoparticles in the delivery of anticancer drugs Biomaterials 30 2009 374 382
36. E. Memisoglu-Bilensoy, A.L. Dogan, and A.A. Hincal Cytotoxic evaluation of injectable cyclodextrin nanoparticles J. Pharm. Pharmacol. 58 2006 585 589
37. M. Harboe, E.B. Thorgersen, and T.E. Mollnes Advances in assay of complement function and activation Adv. Drug Deliv. Rev. 63 2011 976 987
38. S.M. Moghimi, A.J. Andersen, D. Ahmadvand, P.P. Wibroe, T.L. Andresen, and A.C. Hunter Material properties in complement activation Adv. Drug Deliv. Rev. 63 2011 1000 1007
39. N.T. Huynh, E. Roger, N. Lautram, J.P. Benoit, and C. Passirani The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting Nanomedicine 5 9 2010 1415 1433
40. M. Vittaz, D. Bazile, G. Spenlehauer, T. Verrecchia, M. Veillard, and F. Puisieux Effect of PEO surface density on long circulating PLA-PEO nanoparticles which are very low complement activators Biomaterials 17 1996 1575 1581